Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    - The page revision has been updated to v3.6.5. The previous revision indicator v3.6.4 has been replaced.
    Difference
    0.0%
    Check dated 2026-08-08T18:29:51.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record now includes new registry identifiers (UTN and EU CT) and adds data-sharing resources: a PDF with data-access procedures and an external data-sharing site, while older EngageZone links were removed. These changes place the trial's data-sharing framework and identifiers into current reference points for researchers and stakeholders.
    Difference
    0.1%
    Check dated 2026-08-01T15:24:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the underlying documentation/system. This change is an internal version update rather than a visible content update.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:37.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed. This indicates the page's revision history has been updated.
    Difference
    0.0%
    Check dated 2026-07-03T22:30:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.0 to v3.6.2, indicating a patch-level update to the page. This update does not alter study content or results.
    Difference
    0.0%
    Check dated 2026-06-26T19:59:24.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A recruitment-status indicator was added, signaling that the study is no longer recruiting participants. Additionally, new navigation/help items were added, the Interventions header formatting was standardized to Intervention/Treatment, and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T13:30:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.